GraceFinance · Source-backed public company research
Abivax S.A. (ABVX)
Nasdaq · Manufacturing · Pharmaceutical Preparations
Core research established · 4/4 core data layers currently established
What Abivax S.A. does
A.History and Development of the Company Our legal and commercial name is Abivax SA. We were incorporated as a société anonyme (limited liability company) under the laws of France on December 4, 2013 for a period of 99 years until December 22, 2112, subject to extension or early dissolution and registered at the Paris Trade and Company Register on December 27, 2013 under the number 799 363 718. Our principal executive offices are located at 7-11 boulevard Haussmann 75009 Paris, France, and our telephone number is +33 (0) 1 53 83 09 63. We have one wholly owned subsidiary, Abivax LLC, a Delaware limited liability company, formed on March 20, 2023. Our agent for service of process in the United States is CT Corporation System, 1015 15th Street N.W., Suite 1000, Washington, D.C. 20005. We have been listed on Euronext Paris since June 2015.
Open the company story
The live GraceFinance page shows source-backed financial changes, management context, guidance, confirmed events, risks, and connected history only when the applicable evidence and relationships have been established. Missing research stays visible instead of being inferred.